Sakr, Fatemah A. http://orcid.org/0000-0002-4120-0960
Grothe, Michel J.
Cavedo, Enrica
Jelistratova, Irina
Habert, Marie-Odile
Dyrba, Martin
Gonzalez-Escamilla, Gabriel
Bertin, Hugo
Locatelli, Maxime
Lehericy, Stephane
Teipel, Stefan
Dubois, Bruno
Hampel, Harald
,
Bakardjian, Hovagim
Benali, Habib
Bertin, Hugo
Bonheur, Joel
Boukadida, Laurie
Boukerrou, Nadia
Cavedo, Enrica
Chiesa, Patrizia
Colliot, Olivier
Dubois, Bruno
Dubois, Marion
Epelbaum, Stéphane
Gagliardi, Geoffroy
Genthon, Remy
Habert, Marie-Odile
Hampel, Harald
Houot, Marion
Kas, Aurélie
Lamari, Foudil
Levy, Marcel
Lista, Simone
Metzinger, Christiane
Mochel, Fanny
Nyasse, Francis
Poisson, Catherine
Potier, Marie-Claude
Revillon, Marie
Santos, Antonio
Andrade, Katia Santos
Sole, Marine
Surtee, Mohmed
de Schotten, Michel Thiebaud
Vergallo, Andrea
Younsi, Nadjia
,
Aguilar, Lisi Flores
Babiloni, Claudio
Baldacci, Filippo
Benda, Norbert
Black, Keith L.
Bokde, Arun L. W.
Bonuccelli, Ubaldo
Broich, Karl
Bun, René S.
Cacciola, Francesco
Castrillo, Juan
Cavedo, Enrica
Ceravolo, Roberto
Chiesa, Patrizia A.
Colliot, Olivier
Coman, Cristina-Maria
Corvol, Jean-Christophe
Cuello, Augusto Claudio
Cummings, Jeffrey L.
Depypere, Herman
Dubois, Bruno
Duggento, Andrea
Durrleman, Stanley
Escott-Price, Valentina
Federoff, Howard
Ferretti, Maria Teresa
Fiandaca, Massimo
Frank, Richard A.
Garaci, Francesco
Genthon, Remy
George, Nathalie
Giorgi, Filippo S.
Graziani, Manuela
Haberkamp, Marion
Habert, Marie-Odile
Hampel, Harald
Herholz, Karl
Karran, Eric
Kim, Seung H.
Koronyo, Yosef
Koronyo-Hamaoui, Maya
Lamari, Foudil
Langevin, Todd
Lehéricy, Stéphane
Lista, Simone
Lorenceau, Jean
Mapstone, Mark
Neri, Christian
Nisticò, Robert
Nyasse-Messene, Francis
O’bryant, Sid E.
Perry, George
Ritchie, Craig
Rojkova, Katrine
Rossi, Simone
Saidi, Amira
Santarnecchi, Emiliano
Schneider, Lon S.
Sporns, Olaf
Toschi, Nicola
Verdooner, Steven R.
Vergallo, Andrea
Villain, Nicolas
Welikovitch, Lindsay A.
Woodcock, Janet
Younesi, Erfan
Funding for this research was provided by:
Program “Investissements d’avenir” (ANR-10-IAIHU-06 (Agence Nationale de la Recherche-10-IA Agence Institut Hospitalo-Universitaire-6))
Program 'Infrastructure d’avenir en Biologie Santé (ANR-11-INBS-0006’)
Program "CHU de Bordeaux" ((coordination CIC EC7))
Marie-Curie Innovative Training Network BBDiag (Project ID: 721281)
Article History
Received: 21 July 2018
Accepted: 7 January 2019
First Online: 31 January 2019
Change Date: 14 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13195-022-01025-4
Ethics approval and consent to participate
: The ethics committee of the Pitié-Salpêtrière University Hospital approved the study protocol. All participants signed an informed consent form, given and explained to them 2 weeks before enrolment.
: The authors declare that they have no competing interests. HH serves as the Senior Associate Editor for the Journal Alzheimer’s and Dementia; he received lecture fees from Biogen and Roche, research grants from Pfizer, Avid, and MSD Avenir (paid to the institution), travel funding from Functional Neuromodulation, Axovant, Eli Lilly and company, Takeda and Zinfandel, GE-Healthcare and Oryzon Genomics, consultancy fees from Jung Diagnostics, Cytox Ltd., Axovant, Anavex, Takeda and Zinfandel, GE Healthcare, Oryzon Genomics, and Functional Neuromodulation, and participated in scientific advisory boards of Functional Neuromodulation, Axovant, Eli Lilly and company, Cytox Ltd., GE Healthcare, Takeda and Zinfandel, Oryzon Genomics and Roche Diagnostics.HH is a co-inventor in the following patents as a scientific expert and has received no royalties:• In Vitro Multi-parameter Determination Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Patent Number: 8916388.• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases Patent Number: 8298784.• Neurodegenerative Markers for Psychiatric Conditions Publication Number: 20120196300.• In Vitro Multi-parameter Determination Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Publication Number: 20100062463.• In Vitro Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Publication Number: 20100035286.• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases Publication Number: 20090263822.• In Vitro Method for The Diagnosis of Neurodegenerative Diseases Patent Number: 7547553.• CSF Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases Publication Number: 20080206797.• In Vitro Method for The Diagnosis of Neurodegenerative Diseases Publication Number: 20080199966.• Neurodegenerative Markers for Psychiatric Conditions Publication Number: 20080131921.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.